Lv11
30 积分 2025-12-21 加入
Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
4分钟前
待确认
Richardson PG, Siegel DS, Vij R, et al. Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study. Blood. 2014;123(12):1826-1832
18分钟前
已完结
Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial
31分钟前
已完结
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study
46分钟前
已完结
Quality Control in the Endoplasmic Reticulum: Crosstalk between ERAD and UPR pathways
1小时前
已完结
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
1小时前
已完结
Prognostic Evaluation of Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score and Hematological Indices in Classic Hodgkin Lymphoma
30天前
已完结
The effect of haemoglobin, albumin, lymphocyte and platelet score on the prognosis in patients with multiple myeloma
30天前
已完结
皖公网安备34019202002308
